
Annual report 2025
added 02-24-2026
Alphatec Holdings Cash Flow 2011-2026 | ATEC
Annual Cash Flow Alphatec Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
45.2 M | -44.7 M | -78.5 M | -75.1 M | -73.3 M | -46.4 M | -33.1 M | -25.6 M | -8.73 M | -9.96 M | 10.1 M | -20.3 M | 7.81 M | 11.6 M | 13.4 M |
Depreciation & Amortization |
77.5 M | 78.4 M | 56.1 M | 41.2 M | 26.8 M | 10.9 M | 7.58 M | 6.79 M | 7.48 M | 12.4 M | 19 M | 18.4 M | 26.3 M | 23.8 M | 19.9 M |
Accounts Payables |
40.9 M | 53 M | 49 M | 34.7 M | 25.7 M | 17.6 M | 7.77 M | 4.4 M | 3.88 M | 8.7 M | 14.2 M | 10.1 M | 10.8 M | 15.2 M | 17.4 M |
Accounts Receivables |
97.3 M | 83 M | 72.6 M | 60.1 M | 41.9 M | 23.5 M | 16.2 M | 15.1 M | 14.8 M | 18.5 M | 38.3 M | 40.4 M | 41.4 M | 41 M | 41.7 M |
Total Inventories |
169 M | 175 M | 137 M | 102 M | 91.7 M | 46 M | 34.9 M | 28.8 M | 27.3 M | 30.1 M | 44.9 M | 41.7 M | 41.9 M | 49.9 M | 45.9 M |
All numbers in USD currency
Quarterly Cash Flow Alphatec Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -5.04 M | - | - | - | -38.4 M | - | - | - | -18.3 M | - | -66.7 M | - | -24.7 M | - | -58.6 M | - | -18.6 M | - | -39.7 M | -30.1 M | -17 M | - | -24.1 M | -14.6 M | -7.94 M | - | -16.5 M | -8.71 M | -5.3 M | - | -8.11 M | -6.48 M | -6.05 M | - | -126 K | 10.1 M | 210 K | - | - | - | - | - | - | - | - | - | - | - | -336 K | - | - | - | -1.43 M | - | 11.1 M | 4.56 M | 1.61 M |
Depreciation & Amortization |
15 M | 19.9 M | - | 16.5 M | 15.7 M | 17.9 M | - | 10.7 M | 9.8 M | 11.7 M | - | 8 M | 7.5 M | 9.32 M | - | 18 M | 5 M | 3.85 M | - | 7.8 M | 5.06 M | 2.45 M | - | 5.35 M | 3.43 M | 1.78 M | - | 5.07 M | 3.48 M | 1.89 M | - | 5.54 M | 3.74 M | 1.87 M | - | 10.4 M | 7.38 M | 3.88 M | - | 14.1 M | 9.59 M | 4.16 M | - | 14 M | 9.56 M | 4.85 M | - | 20 M | 12.6 M | 6.26 M | - | 17.4 M | 11.6 M | 5.8 M | - | 14.9 M | 9.98 M | 5 M |
Accounts Payables |
47.2 M | 38.8 M | 53 M | 59.6 M | 72.7 M | 60.4 M | 49 M | 50.1 M | 43.7 M | 39.1 M | 34.7 M | 33.4 M | - | 34 M | 25.7 M | 29.4 M | 29.8 M | 26.4 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 7.77 M | 7.77 M | 7.77 M | 7.77 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 3.88 M | 3.88 M | 3.88 M | 3.88 M | 8.7 M | 8.7 M | 8.7 M | 8.7 M | 13.5 M | 13.5 M | 14.2 M | 14.2 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 10.8 M | 10.8 M | 10.8 M | 10.8 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M |
Accounts Receivables |
95.9 M | 89.5 M | 83 M | 78.5 M | 84 M | 88.6 M | 72.6 M | 64.5 M | 59.9 M | 62.4 M | 60.1 M | 50.7 M | - | 40.4 M | 41.9 M | 33.7 M | 33.7 M | 25.8 M | 23.5 M | 23.5 M | 23.5 M | 23.5 M | 16.2 M | 16.2 M | 16.2 M | 16.2 M | 15.1 M | 15.1 M | 15.1 M | 15.1 M | 14.8 M | 14.8 M | 14.8 M | 14.8 M | 18.5 M | 18.5 M | 18.5 M | 18.5 M | 26.9 M | 26.9 M | 38.3 M | 38.3 M | 40.4 M | 40.4 M | 40.4 M | 40.4 M | 41.4 M | 41.4 M | 41.4 M | 41.4 M | 41 M | 41 M | 41 M | 41 M | 41.7 M | 41.7 M | 41.7 M | 41.7 M |
Total Inventories |
170 M | 171 M | 175 M | 183 M | 172 M | 153 M | 137 M | 131 M | 120 M | 108 M | 102 M | 102 M | - | 99 M | 91.7 M | 92.5 M | 86.7 M | 57.4 M | 46 M | 46 M | 46 M | 46 M | 34.9 M | 34.9 M | 34.9 M | 34.9 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 30.1 M | 30.1 M | 30.1 M | 30.1 M | 32.6 M | 32.6 M | 44.9 M | 44.9 M | 41.7 M | 41.7 M | 41.7 M | 41.7 M | 41.9 M | 41.9 M | 41.9 M | 41.9 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 45.9 M | 45.9 M | 45.9 M | 45.9 M |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company Alphatec Holdings, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Medical devices sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
$ 14.09 | -7.06 % | $ 381 M | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
$ 31.87 | 2.07 % | $ 1.47 B | ||
|
Cognyte Software Ltd.
CGNT
|
$ 7.0 | 5.74 % | $ 503 M | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.38 | -4.58 % | $ 163 M | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | ||
|
Electromed
ELMD
|
$ 24.18 | 1.09 % | $ 204 M | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
$ 3.49 | 2.05 % | $ 121 M | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | ||
|
Bio-Rad Laboratories
BIO
|
$ 275.33 | 2.19 % | $ 7.77 B | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
$ 40.88 | 2.48 % | $ 6.09 K | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
$ 75.65 | 2.97 % | $ 112 B | ||
|
InMode Ltd.
INMD
|
$ 14.0 | 0.29 % | $ 905 M | ||
|
IRIDEX Corporation
IRIX
|
$ 1.47 | -2.0 % | $ 23.7 M | ||
|
IRadimed Corporation
IRMD
|
$ 102.4 | 1.89 % | $ 1.3 B | ||
|
CONMED Corporation
CNMD
|
$ 45.89 | -0.18 % | $ 1.42 B | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | ||
|
LivaNova PLC
LIVN
|
$ 71.26 | 1.38 % | $ 3.89 B | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
$ 97.22 | 0.58 % | $ 125 B | ||
|
Delcath Systems
DCTH
|
$ 9.11 | -10.77 % | $ 260 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
$ 2.48 | 1.02 % | $ 146 M | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
$ 77.41 | -1.12 % | $ 2.18 B | ||
|
Insulet Corporation
PODD
|
$ 251.74 | 1.46 % | $ 17.7 B | ||
|
Quanterix Corporation
QTRX
|
$ 6.7 | 6.52 % | $ 252 M | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | ||
|
FONAR Corporation
FONR
|
$ 18.53 | -0.3 % | $ 121 M | ||
|
Sintx Technologies
SINT
|
$ 2.89 | -1.87 % | $ 10.8 M | ||
|
MiMedx Group
MDXG
|
$ 4.97 | -5.78 % | $ 735 M |